Irreversible corneal decompensation in patients treated with topical dorzolamide.
Adamsons
I
I
D000287:Administration, Topical; D002257:Carbonic Anhydrase Inhibitors / Q000009:adverse effects*; D015715:Corneal Edema / Q000139:chemically induced*; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D013449:Sulfonamides / Q000009:adverse effects*; D013876:Thiophenes / Q000009:adverse effects*
D002257:Carbonic Anhydrase Inhibitors; D013449:Sulfonamides; D013876:Thiophenes; C062765:dorzolamide